Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Neoplasms 2 Melanoma 2 Carcinoma, Hepatocellular 2 Uveal Melanoma 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Liver Neoplasms 1 Glioma 1 Glioblastoma 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Brain Neoplasms 1 Advanced Solid Tumors 1 Advanced Cancer 1

Interventions

Injections 18 Carboplatin 14 Docetaxel 11 pembrolizumab 8 durvalumab 7 Cisplatin 6 linifanib 5 Paclitaxel 5 Nivolumab 5 zimberelimab 4 talazoparib 4 olaparib 4 Panobinostat 4 Itraconazole 4 Bevacizumab 4 tremelimumab 3 sintilimab 3 depatuxizumab 3 atezolizumab 3 ST 1481 3 S 1 (combination) 3 Rifampin 3 Pemetrexed 3 Oxaliplatin 3 Fluorouracil 3 Everolimus 3 Drug Therapy 3 trifluridine tipiracil drug combination 2 trametinib 2 toripalimab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Advanced Solid Tumors × relatlimab × Clear all

NCT05498480 2024-02-20

RELATIVITY-111

Bristol-Myers Squibb

Phase 1 Completed

Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡